ANN ARBOR, Mich. -- One of the largest U.S. cancer clinical trial networks will undertake a clinical trial, supported by a $2,520,905 grant from the Bill & Melinda Gates Foundation to the University of Michigan, to find the most effective way to eradicate an extremely common bacterial infection that is the principal known cause of stomach cancer.